Fellas (and ladies) what gives???? That scoping study was to be released by the end of October. It's getting towards the end of November! I'm hoping no news is good news, that something positive has come up for shareholders that has caused this delay, I hope so anyway. And GZ, I also know that I wrote that back in September that Juruena could/will be huge from what I'm hearing, or I simple could be a sucker, I pray it's not the latter. Without any info week after week, it gets harder and harder to remain confident, lol. Sentiment still remains "buy", only just though, another week without news will shift it to hold.
CAS Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
